一个针对整合互补激活信号的仿制抗原受体增强了NK细胞的抗瘤活性
Eunbi Yi1,2, Eunbi Lee1, Hyo Jin Park1,2
1Department of Microbiology, Brain Korea 21 Project, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Journal of experimental & clinical cancer research : CR
|March 5, 2025
概括
通过量身定制组件,针对自然杀手 (NK) 细胞优化了仿真抗原受体 (CAR),从而提高了对CD19+淋巴瘤的CAR-NK细胞功效. 与传统的CAR-T细胞相比,这种针对NK的CAR显示出更好的抗瘤活性.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞疗法细胞疗法
- 癌症研究 癌症研究
背景情况:
- 化学抗原受体 (CARs) 重编程效应细胞,但传统的设计是T细胞专注的,而不是针对自然杀手 (NK) 细胞进行优化.
- 与CAR-T细胞相比,CAR-NK细胞提供了优势,包括提高安全性,现货可用性和减少抗原逃逸,推动了对NK特异性CAR优化的需求.
研究的目的:
- 为增强NK细胞激活和功能量身定制CAR结构.
- 为基于NK细胞的CAR确定链,跨膜和信号域的最佳组合.
主要方法:
- 系统地修改CAR组件 (链,跨膜,信号域) 以优化NK细胞激活.
- 在体外和体内评估NK定制的CAR功能在CD19表达淋巴瘤模型.
- 评估NK细胞内的CAR表达和信号特性.
主要成果:
- 由NKG2D和2B4NK受体驱动的NK-CARs显示出强大的NK细胞激活,表现优于使用DNAM-1和2B4的NK-CARs.
- 一个特定的NK量身定制的CAR结构 (DAP10,2B4,CD3ζ信号域与CD8α链和CD28跨膜域) 显示出卓越的CAR介导细胞毒性.
- 与 NK 细胞中的传统 CAR-T 结构相比,这种优化 NK 量身定制的 CAR 在体外和体内都表现出增强的抗瘤活性.
结论:
- 基于NK受体的域对于设计有效的NK-CAR是非常有前途的.
- 量身定制的NK-CAR具有在癌症治疗中的治疗应用的巨大潜力.
关键词:
2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B4 2B5 2B5 2B6 2B6 2B7 2B8 2B8 2B9 2B9 2B9 2B9 2B9 2B9 2B9 2B9化学抗原受体的化学抗原受体在 DAP10 中使用 DAP10.自然杀手细胞是自然杀手细胞.协同信号传输是一种协同信号传输.
相关概念视频
01:27Cytotoxic T Cells-mediated Immune Response
825
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
825
01:27Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457